Helicobacter pylori treatment in Turkey: Current status and rational treatment options

According to the TURHEP study, the prevalence of Helicobacter pylori in Turkey is 82.5%. After FDA approval in 1995, many countries have used standard triple therapy (proton pump inhibitor 40 mg b.i.d clarithromycin 500 mg b.i.d and amoxicillin 1 gr b.i.d) for Helicobacter pylori treatment. In the b...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaplan, Mustafa, Tanoglu, Alpaslan, Duzenli, Tolga, Tozun, Ayse Nurdan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103748/
https://www.ncbi.nlm.nih.gov/pubmed/32232212
http://dx.doi.org/10.14744/nci.2019.62558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103748/
https://www.ncbi.nlm.nih.gov/pubmed/32232212
http://dx.doi.org/10.14744/nci.2019.62558

Ejemplares similares